1. PB1829: ARGENTINEAN REAL WORLD EXPERIENCE ON MIDOSTAURIN PLUS INTENSIVE CHEMOTHERAPY VS INTENSIVE CHEMOTHERAPY TO TREAT FLT3 POSITIVE ACUTE MYELOID LEUKEMIA PATIENTS. (23rd June 2022) Authors: Navickas, A.; González, J.; Rivas, M. M.; Clavijo, M.; Carnelutto, N.; Funes, M. E.; Mela Osorio, M. J.; Mariano, R.; Rapan, M. L.; Moirano, M.; Rey, I.; Cranco, S.; Giunta, J. E.; Ramirez, R.; Castro, M. B.; Enrico, A.; Gimenez Conca, A.; Belli, C. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 1709 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗